CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members
Alexander Fleming Biomedical Sciences Research Center · Breast Cancer Research Foundation · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
968
total citations
- FWCI
- 22.19
- Percentile
- 100%
- References
- 27
Citations per year
Authors
6- ETEirini TrompoukiCorresponding
Alexander Fleming Biomedical Sciences Research Center
- EHEudoxia Hatzivassiliou
Alexander Fleming Biomedical Sciences Research Center
- TTTheodore Tsichritzis
Alexander Fleming Biomedical Sciences Research Center
- HFHannah Farmer
Breast Cancer Research Foundation, Institute of Cancer Research, Cancer Research UK
- AAAlan Ashworth
Institute of Cancer Research, Breast Cancer Research Foundation, Cancer Research UK
Topics & keywords
Keywords
- Deubiquitinating enzyme
- Transcription factor
- NF-κB
- NFKB1
- Biology
- TRAF2
- Downregulation and upregulation
- Cell biology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.